Who Interprets Your Tissue Data? The Case for Embedded Pathology in Complex Biomarker Programs

• Complex tissue biomarker assays require pathology expertise at design, not just at review
• Pathologists interpret data – they don't just quality-control it
• Not every assay needs GLP. Regulatory agility means applying the right compliance framework to the right stage

Speakers:

Pierre Moulin

Chief Scientific Officer

Diagnexia Analytix